000 | 01199 a2200313 4500 | ||
---|---|---|---|
005 | 20250517015922.0 | ||
264 | 0 | _c20151103 | |
008 | 201511s 0 0 eng d | ||
022 | _a1520-4383 | ||
024 | 7 |
_a10.1182/asheducation-2014.1.559 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaude, Shannon L | |
245 | 0 | 0 |
_aChimeric antigen receptor T-cell therapy for ALL. _h[electronic resource] |
260 |
_bHematology. American Society of Hematology. Education Program _cDec 2014 |
||
300 |
_a559-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntigens, CD19 _ximmunology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _ximmunology |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aShpall, Elizabeth J | |
700 | 1 | _aGrupp, Stephan A | |
773 | 0 |
_tHematology. American Society of Hematology. Education Program _gvol. 2014 _gno. 1 _gp. 559-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/asheducation-2014.1.559 _zAvailable from publisher's website |
999 |
_c24638041 _d24638041 |